REG - ConvaTec Group PLC - Scrip Dividend - calculation price

ConvaTecAnnouncement

13/09/2018 16:00

RNS Number : 7388A
ConvaTec Group PLC
13 September 2018
 


 
 
 
Scrip Dividend - calculation price
 
Reading, United Kingdom (13 September 2018)
On 1 August 2018 ConvaTec Group Plc ("ConvaTec" or "the Company") declared an interim dividend of 1.717 cents per share (the "interim dividend"). This interim dividend is to be paid on 12 October 2018 to shareholders on the share register as at 7 September 2018 ("record date"). The dividend is payable in cash in sterling to holders of ordinary shares, the chosen exchange rate for this payment is $1.312/£1.00, determined on 1 August 2018, giving a total sterling dividend of £25,669,593.70. On 2 August 2018 the Company announced that a scrip dividend will be made available for this interim dividend allowing shareholders to elect to receive their dividend in the form of new ordinary shares.
The "Calculation Price" for the issue of new ordinary shares under the scrip dividend scheme is: 
228.08 pence for each new ordinary share
This is equivalent to 1 new share for approximately 174.28 shares held prior to the ex-dividend date of 6 September 2018
The Calculation Price is the average of the middle market quotations of a ConvaTec share, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 6 September to 12 September 2018 (inclusive).
The latest date for receipt of elections to participate in the scrip dividend scheme for this interim dividend is 21 September 2018. Shareholders must return their mandate form by 5pm (GMT) or otherwise input their CREST elections to be received by the Company's registrar, Computershare, by 3pm (GMT) on 21 September 2018. Elections received after this deadline will apply to subsequent dividends only. Unless revoked by you, your scrip dividend election will apply for all future dividends for which a scrip dividend is offered. Evergreen elections for CREST shareholders cannot be accepted and elections will revert to cash by default after the payment of each dividend.
Details of the scrip dividend scheme are available at www.convatecgroup.com/investors.
TIMETABLE
Key dates in respect of the scrip dividend scheme for the interim dividend are:




  Ex-dividend Date


6 September 2018




  Record Date


7 September 2018




  Scrip calculation price determined


6-12 September 2018 (inclusive)




  Scrip calculation price available and announced


13 September 2018




  Mandate delivery deadline for Shares held in uncertificated form


3.00 p.m. on 21 September 2018




  Mandate delivery deadline for Shares held in certificated form


5.00 p.m. on 21 September 2018




  Announcement of the total amount of new shares to be issued


                      28 September 2018




  Dividend payment date


12 October 2018




Dispatch of statement in accordance with section 7 of Scheme Rules and share certificates, CREST accounts credited/updated, and first day of dealings in New Shares


12 October 2018




 
Enquiries
 
Media
 
Bobby Leach, VP Group Corporate Affairs, ConvaTec                    +44 (0)7770 842 226
Alastair Elwen, Finsbury                                                                  +44 (0)207 251 3801
Analysts and Investors
 
John Crosse, VP Investor Relations, ConvaTec                             +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec                         +44 (0)7470 909 582
investorrelations@convatec.com
 
LEI:   213800LS272L4FIDOH92
 
About ConvaTec
 
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
 
 
# # #
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVFKNDPQBKDPCD